609 Results

People

  1. Lilja
    Lilja
  2. Vickers
    Vickers
  3. Scher
    Scher
  4. Eastham
    Eastham
  5. Scardino
    Scardino
  6. Zelefsky
    Zelefsky
  7. Kattan
    Kattan
  8. Carlsson
    Carlsson
  9. Kelly
    Kelly
  10. Slovin
    Slovin

Groups

  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)
  7. Department of Medicine (143)
  8. Solid Tumor Oncology Division (138)
  9. Genitourinary Oncology Service (135)
  10. Health Outcomes Research Group (133)
  1. "prostate-specific antigen"
Formats
  1. Journal Article (570)
  2. Editorial (8)
  3. Review (8)
  4. Conference Paper (6)
  5. Guidelines (5)
  6. Meeting Abstract (4)
  7. Book Section (3)
  8. Correspondence (3)
  9. Research Letter (2)
Groups
  1. Surgery (295)
  2. Urology (293)
  3. Population Sciences Research Program (215)
  4. Epidemiology and Biostatistics (178)
  5. Sloan Kettering Institute Faculty (171)
  6. Molecular Pharmacology and Chemistry Program Faculty (168)

More Groups

People
  1. Hans Lilja (135)
  2. Peter Scardino (117)
  3. Andrew Vickers (98)
  4. Howard Scher (96)
  5. James Eastham (80)
  6. Michael Zelefsky (64)

More People

Years
  1. 2025 (3)
  2. 2024 (26)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Urology (69)
  2. European Urology (47)
  3. International Journal of Radiation Oncology, Biology, Physics (40)
  4. Journal of Clinical Oncology (39)
  5. Urology (36)
  6. Clinical Cancer Research (31)

More Publications

Publishers
  1. Elsevier Science, Inc. (162)
  2. Elsevier Inc. (72)
  3. Wiley Blackwell (64)
  4. American Association for Cancer Research (46)
  5. American Society of Clinical Oncology (39)
  6. John Wiley & Sons (29)

More Publishers

Results (609)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: Results from the Gothenburg Randomized Screening Trial
    Journal Article

    Frånlund, M.; Carlsson, S.; Stranne, J.; Aus, G.; Hugosson, J.
    BJU International (2012)

    Fulltext@MSK | Save
  • Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology provisional clinical opinion
    Journal Article

    Basch, E.; Oliver, T. K.; Vickers, A.; Thompson, I.; Kantoff, P.; Parnes, H.; Loblaw, D. A.; Roth, B.; Williams, J.; Nam, R. K.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
    Journal Article

    Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial
    Journal Article

    Vickers, A.; Bennette, C.; Steineck, G.; Adami, H. O.; Johansson, J. E.; Bill-Axelson, A.; Palmgren, J.; Garmo, H.; Holmberg, L.
    European Urology (2012)

    Fulltext@MSK | Save
  • Prostate cancer screening: Facts, statistics, and interpretation in response to the US Preventive Services Task Force review
    Journal Article

    Carlsson, S.; Vickers, A. J.; Roobol, M.; Eastham, J.; Scardino, P.; Lilja, H.; Hugosson, J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Zelefsky, M. J.; Chou, J. F.; Pei, X.; Yamada, Y.; Kollmeier, M.; Cox, B.; Zhang, Z.; Schechter, M.; Cohen, G. N.; Zaider, M.
    Brachytherapy (2012)

    Fulltext@MSK | Save
  • A novel automated platform for quantifying the extent of skeletal tumour involvement in prostate cancer patients using the bone scan index
    Journal Article

    Ulmert, D.; Kaboteh, R.; Fox, J. J.; Savage, C.; Evans, M. J.; Lilja, H.; Abrahamsson, P. A.; Björk, T.; Gerdtsson, A.; Bjartell, A.; more...
    European Urology (2012)

    Fulltext@MSK | Save
  • A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen
    Journal Article

    Gregor, P.; Huang, Q. D.; Gallardo, H. F.; Rasalan, T. S.; Morris, M. J.
    Clinical Genitourinary Cancer (2012)

    Fulltext@MSK | Save
  • Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone
    Journal Article

    Evans-Axelsson, S.; Ulmert, D.; Örbom, A.; Peterson, P.; Nilsson, O.; Wennerberg, J.; Strand, J.; Wingårdh, K.; Olsson, T.; Hagman, Z.; more...
    Cancer Biotherapy and Radiopharmaceuticals (2012)

    Fulltext@MSK | Save
  • Predicting prostate cancer many years before diagnosis: How and why?
    Journal Article

    Vickers, A. J.; Lilja, H.
    World Journal of Urology (2012)

    Fulltext@MSK | Save